Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003422 |
---|---|
Receipt number | R000004122 |
Scientific Title | A phase II study of erlotinib/S-1 combination therapy in patients with recurrent or advanced non-small lung cancer who do not possess active EGFR mutation.(TORG0913) |
Date of disclosure of the study information | 2010/03/31 |
Last modified on | 2020/11/12 10:39:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/03/31 21:50:37 | ||
2 | Update | 2010/10/04 11:39:14 | Name of person sending information Organization Division name Address |
|
3 | Update | 2011/10/07 11:36:40 | Recruitment status |
|
4 | Update | 2011/10/07 11:39:01 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2014/07/18 10:49:40 | Email |
|
6 | Update | 2020/11/12 10:39:53 | Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |